Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ramipril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Ramipril. |
| Fosinopril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Fosinopril. |
| Trandolapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Trandolapril. |
| Benazepril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Benazepril. |
| Enalapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Enalapril. |
| Moexipril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Moexipril. |
| Lisinopril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Lisinopril. |
| Perindopril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Perindopril. |
| Quinapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Quinapril. |
| Omapatrilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Omapatrilat. |
| Rescinnamine | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Rescinnamine. |
| Captopril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Captopril. |
| Cilazapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Cilazapril. |
| Spirapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Spirapril. |
| Temocapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Temocapril. |
| Enalaprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Enalaprilat. |
| Imidapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Imidapril. |
| Zofenopril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Zofenopril. |
| Delapril | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Delapril. |
| Benazeprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Benazeprilat. |
| Fosinoprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Fosinoprilat. |
| Ramiprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Ramiprilat. |
| Trandolaprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Trandolaprilat. |
| Moexiprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Moexiprilat. |
| Perindoprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Perindoprilat. |
| Quinaprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Quinaprilat. |
| Cilazaprilat | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Cilazaprilat. |
| Triamterene | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Triamterene. |
| Spironolactone | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Spironolactone. |
| Amiloride | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Amiloride. |
| Eplerenone | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Eplerenone. |
| Canrenoic acid | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Canrenoic acid. |
| Canrenone | The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Canrenone. |
| Torasemide | The risk or severity of dehydration can be increased when Torasemide is combined with Potassium lactate. |
| Methyclothiazide | The risk or severity of dehydration can be increased when Methyclothiazide is combined with Potassium lactate. |
| Chlorthalidone | The risk or severity of dehydration can be increased when Chlorthalidone is combined with Potassium lactate. |
| Ethoxzolamide | The risk or severity of dehydration can be increased when Ethoxzolamide is combined with Potassium lactate. |
| Bendroflumethiazide | The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Potassium lactate. |
| Metolazone | The risk or severity of dehydration can be increased when Metolazone is combined with Potassium lactate. |
| Benzthiazide | The risk or severity of dehydration can be increased when Benzthiazide is combined with Potassium lactate. |
| Cyclothiazide | The risk or severity of dehydration can be increased when Cyclothiazide is combined with Potassium lactate. |
| Furosemide | The risk or severity of dehydration can be increased when Furosemide is combined with Potassium lactate. |
| Methazolamide | The risk or severity of dehydration can be increased when Methazolamide is combined with Potassium lactate. |
| Mannitol | The risk or severity of dehydration can be increased when Mannitol is combined with Potassium lactate. |
| Hydroflumethiazide | The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Potassium lactate. |
| Indapamide | The risk or severity of dehydration can be increased when Indapamide is combined with Potassium lactate. |
| Acetazolamide | The risk or severity of dehydration can be increased when Acetazolamide is combined with Potassium lactate. |
| Conivaptan | The risk or severity of dehydration can be increased when Conivaptan is combined with Potassium lactate. |
| Chlorothiazide | The risk or severity of dehydration can be increased when Chlorothiazide is combined with Potassium lactate. |
| Bumetanide | The risk or severity of dehydration can be increased when Bumetanide is combined with Potassium lactate. |
| Etacrynic acid | The risk or severity of dehydration can be increased when Etacrynic acid is combined with Potassium lactate. |
| Zonisamide | The risk or severity of dehydration can be increased when Zonisamide is combined with Potassium lactate. |
| Hydrochlorothiazide | The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Potassium lactate. |
| Trichlormethiazide | The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Potassium lactate. |
| Diclofenamide | The risk or severity of dehydration can be increased when Diclofenamide is combined with Potassium lactate. |
| Polythiazide | The risk or severity of dehydration can be increased when Polythiazide is combined with Potassium lactate. |
| Quinethazone | The risk or severity of dehydration can be increased when Quinethazone is combined with Potassium lactate. |
| Drospirenone | The risk or severity of dehydration can be increased when Drospirenone is combined with Potassium lactate. |
| Theobromine | The risk or severity of dehydration can be increased when Theobromine is combined with Potassium lactate. |
| Piretanide | The risk or severity of dehydration can be increased when Piretanide is combined with Potassium lactate. |
| Tienilic acid | The risk or severity of dehydration can be increased when Tienilic acid is combined with Potassium lactate. |
| Ularitide | The risk or severity of dehydration can be increased when Ularitide is combined with Potassium lactate. |
| Tolvaptan | The risk or severity of dehydration can be increased when Tolvaptan is combined with Potassium lactate. |
| Indisulam | The risk or severity of dehydration can be increased when Indisulam is combined with Potassium lactate. |
| Canagliflozin | Potassium lactate may increase the hyperkalemic activities of Canagliflozin. |
| Azosemide | The risk or severity of dehydration can be increased when Azosemide is combined with Potassium lactate. |
| Potassium citrate | The risk or severity of dehydration can be increased when Potassium citrate is combined with Potassium lactate. |
| Efonidipine | The risk or severity of dehydration can be increased when Efonidipine is combined with Potassium lactate. |
| Mersalyl | The risk or severity of dehydration can be increased when Mersalyl is combined with Potassium lactate. |
| Isosorbide | The risk or severity of dehydration can be increased when Isosorbide is combined with Potassium lactate. |
| Rolofylline | The risk or severity of dehydration can be increased when Rolofylline is combined with Potassium lactate. |
| Spiradoline | The risk or severity of dehydration can be increased when Spiradoline is combined with Potassium lactate. |
| Cicletanine | The risk or severity of dehydration can be increased when Cicletanine is combined with Potassium lactate. |
| Meticrane | The risk or severity of dehydration can be increased when Meticrane is combined with Potassium lactate. |
| Mefruside | The risk or severity of dehydration can be increased when Mefruside is combined with Potassium lactate. |
| Mebutizide | The risk or severity of dehydration can be increased when Mebutizide is combined with Potassium lactate. |
| Cyclopenthiazide | The risk or severity of dehydration can be increased when Cyclopenthiazide is combined with Potassium lactate. |
| Clorexolone | The risk or severity of dehydration can be increased when Clorexolone is combined with Potassium lactate. |
| Clofenamide | The risk or severity of dehydration can be increased when Clofenamide is combined with Potassium lactate. |
| Fenquizone | The risk or severity of dehydration can be increased when Fenquizone is combined with Potassium lactate. |
| Clopamide | The risk or severity of dehydration can be increased when Clopamide is combined with Potassium lactate. |
| Muzolimine | The risk or severity of dehydration can be increased when Muzolimine is combined with Potassium lactate. |
| Xipamide | The risk or severity of dehydration can be increased when Xipamide is combined with Potassium lactate. |
| Epitizide | The risk or severity of dehydration can be increased when Epitizide is combined with Potassium lactate. |
| Bromotheophylline | The risk or severity of dehydration can be increased when Bromotheophylline is combined with Potassium lactate. |
| Potassium | The risk or severity of dehydration can be increased when Potassium is combined with Potassium lactate. |
| Potassium cation | The risk or severity of dehydration can be increased when Potassium cation is combined with Potassium lactate. |
| Buthiazide | The risk or severity of dehydration can be increased when Buthiazide is combined with Potassium lactate. |
| Tripamide | The risk or severity of dehydration can be increased when Tripamide is combined with Potassium lactate. |
| Verapamil | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Verapamil. |
| Xylometazoline | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Xylometazoline. |
| Fasudil | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Fasudil. |
| Ziconotide | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Ziconotide. |
| Tramadol | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Tramadol. |
| Morphine | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Morphine. |
| Codeine | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Codeine. |
| Hydromorphone | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Hydromorphone. |
| Methadone | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Methadone. |
| Meperidine | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Meperidine. |
| Oxycodone | The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Oxycodone. |